These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 25311677)
1. Decade in review-urinary incontinence: advances in female urology and voiding dysfunction. Clifton MM; Goldman HB Nat Rev Urol; 2014 Nov; 11(11):613-4. PubMed ID: 25311677 [No Abstract] [Full Text] [Related]
2. Urinary incontinence in women. Wood LN; Anger JT BMJ; 2014 Sep; 349():g4531. PubMed ID: 25225003 [TBL] [Abstract][Full Text] [Related]
3. OnabotulinumtoxinA is Preferred over Sacral Neuromodulation for Refractory Overactive Bladder: Pro. Ginsberg DA J Urol; 2017 Jan; 197(1):11-13. PubMed ID: 27742453 [No Abstract] [Full Text] [Related]
4. OnabotulinumtoxinA is Preferred over Sacral Neuromodulation for Refractory Overactive Bladder: Con. Siegel S J Urol; 2017 Jan; 197(1):11-13. PubMed ID: 27742452 [No Abstract] [Full Text] [Related]
5. A Comparative Observational Study to Evaluate the Efficacy of Mid-Urethral Sling with Botulinum Toxin A Injection in Urinary Incontinence Patients. Chang YH; Hsiao PJ; Chi-Ping H; Wu HC; Hsieh PF; Chou EC Toxins (Basel); 2020 Jun; 12(6):. PubMed ID: 32498306 [TBL] [Abstract][Full Text] [Related]
6. Stress urinary incontinence and overactive bladder syndrome: current options and new targets for management. Elser DM Postgrad Med; 2012 May; 124(3):42-9. PubMed ID: 22691898 [TBL] [Abstract][Full Text] [Related]
7. Long-Term Treatment with OnabotulinumtoxinA Results in Consistent, Durable Improvements in Health Related Quality of Life in Patients with Overactive Bladder. Ginsberg DA; Drake MJ; Kaufmann A; Radomski S; Gousse AE; Chermansky CJ; Magyar A; Nicandro JP; Nitti VW; J Urol; 2017 Oct; 198(4):897-904. PubMed ID: 28536084 [TBL] [Abstract][Full Text] [Related]
8. Effectiveness of botulinum toxin injection in the treatment of de novo OAB symptoms following midurethral sling surgery. Miotla P; Futyma K; Cartwright R; Bogusiewicz M; Skorupska K; Markut-Miotla E; Rechberger T Int Urogynecol J; 2016 Mar; 27(3):393-8. PubMed ID: 26364180 [TBL] [Abstract][Full Text] [Related]
9. What is the value of urodynamic studies before stress incontinence surgery? Giarenis I; Cardozo L BJOG; 2013 Jan; 120(2):130-132. PubMed ID: 23240793 [No Abstract] [Full Text] [Related]
18. Overactive bladder syndrome - management and treatment options. Arnold J; McLeod N; Thani-Gasalam R; Rashid P Aust Fam Physician; 2012 Nov; 41(11):878-83. PubMed ID: 23145420 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of onabotulinum toxin A injection in pediatric patients with non-neurogenic detrusor overactivity. Bayrak O; Sadioglu E; Sen H; Dogan K; Erturhan S; Seckiner I Neurourol Urodyn; 2017 Nov; 36(8):2078-2082. PubMed ID: 28195356 [TBL] [Abstract][Full Text] [Related]
20. Impact of onabotulinumtoxinA on quality of life and practical aspects of daily living: A pooled analysis of two randomized controlled trials. Everaert K; Gruenenfelder J; Schulte-Baukloh H; Egerdie RB; Khalaf K; Joshi M; Ni Q; Sussman D Int J Urol; 2015 Dec; 22(12):1131-7. PubMed ID: 26391359 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]